[
    [
        {
            "time": "2023-10-01",
            "original_text": "炒股浮亏15亿，老字号云南白药“剑走偏锋”干投资！投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "浮亏",
                    "投资失误"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "炒股浮亏15亿，老字号云南白药“剑走偏锋”干投资！投资失误",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-02",
            "original_text": "CRO企业走势分化，片仔癀领跌中药行业，云南白药炒股亏15亿「制药行业周榜」投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "亏损",
                    "中药行业",
                    "投资失误"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "CRO企业走势分化，片仔癀领跌中药行业，云南白药炒股亏15亿「制药行业周榜」投资失误",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-03",
            "original_text": "云南白药炒股亏11亿，背后的操盘手是谁？投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "亏损",
                    "操盘手",
                    "投资失误"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药炒股亏11亿，背后的操盘手是谁？投资失误",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-04",
            "original_text": "炒股血亏15亿，利润暴跌42%！云南白药转型路在何方？盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "血亏",
                    "利润暴跌",
                    "转型",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "炒股血亏15亿，利润暴跌42%！云南白药转型路在何方？盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "上市公司舆情周报|云南白药炒股巨亏15亿，家乐福与盒马共斥山姆，上市公司副总“切腹”推票投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "巨亏",
                    "舆情",
                    "投资失误"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上市公司舆情周报|云南白药炒股巨亏15亿，家乐福与盒马共斥山姆，上市公司副总“切腹”推票投资失误",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "“炒股”巨亏15亿，云南白药第三季度净利润同比下降64%盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "巨亏",
                    "净利润下降",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“炒股”巨亏15亿，云南白药第三季度净利润同比下降64%盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "云南白药不孤单 这些医药公司投资失利业绩“变脸”盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "医药公司",
                    "投资失利",
                    "业绩变脸",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药不孤单 这些医药公司投资失利业绩“变脸”盈利能力下降",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "A股近900家公司参与证券投资，一半都在亏亏损损",
            "features": {
                "keywords": [
                    "A股",
                    "证券投资",
                    "亏损"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股近900家公司参与证券投资，一半都在亏亏损损",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "斥巨资投资后，有药企开始出现“消化不良”",
            "features": {
                "keywords": [
                    "药企",
                    "投资",
                    "消化不良"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "斥巨资投资后，有药企开始出现“消化不良”",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "云南白药：未来将聚焦骨伤科等领域开展大量专项研究",
            "features": {
                "keywords": [
                    "云南白药",
                    "骨伤科",
                    "专项研究"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "云南白药：未来将聚焦骨伤科等领域开展大量专项研究",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]